An assessment of mismatch repair deficiency in ovarian tumours at a public hospital in Johannesburg, South Africa.

Autor: de Klerk, S. R.¹ sheodk@gmail.com, Wadee, R.² reubinawadee@gmail.com

Publikováno v: South African Journal of Obstetrics & Gynaecology. 2022, Vol. 28 Issue 2, p46-51. 6p.

A comparison of malignant histopathological diagnoses on uterine curettings and hysterectomy specimens.

Autor: Ismail, A.¹ docismail88@gmail.com, Wadee, R.¹ reubinawadee@gmail.com

Publikováno v: South African Journal of Obstetrics & Gynaecology. 2022, Vol. 28 Issue 1, p10-15. 6p.

Discovery and technical validation of high-performance methylated DNA markers for the detection of cervical lesions at risk of malignant progression in low- and middle-income countries.

Autor: Fackler MJ; Women's Malignancies Program, Department of Oncology, Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, 1650 Orleans Street, Rm 144, CRB1, Baltimore, MD, 21231, USA., Pleas M; Women's Malignancies Program, Department of Oncology, Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, 1650 Orleans Street, Rm 144, CRB1, Baltimore, MD, 21231, USA., Li Y; Women's Malignancies Program, Department of Oncology, Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, 1650 Orleans Street, Rm 144, CRB1, Baltimore, MD, 21231, USA., Soni A; Women's Malignancies Program, Department of Oncology, Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, 1650 Orleans Street, Rm 144, CRB1, Baltimore, MD, 21231, USA., Xing D; Women's Malignancies Program, Department of Oncology, Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, 1650 Orleans Street, Rm 144, CRB1, Baltimore, MD, 21231, USA., Cope L; Women's Malignancies Program, Department of Oncology, Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, 1650 Orleans Street, Rm 144, CRB1, Baltimore, MD, 21231, USA., Ali S; Division of Cytopathology, Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Van Le Q; Hanoi Medical University, National Cancer Hospital, Hanoi, Vietnam., Van Nguyen C; Department of Quansu Pathology, National Cancer Hospital, Hanoi, Vietnam., Pham HT; Department of Quansu Pathology, National Cancer Hospital, Hanoi, Vietnam., Duong LM; Department of Quansu Pathology, National Cancer Hospital, Hanoi, Vietnam., Vanden Berg E; Department of Anatomical Pathology, Faculty of Health Sciences, University of the Witwatersrand/National Health Laboratory Service, Johannesburg, South Africa., Wadee R; Department of Anatomical Pathology, Faculty of Health Sciences, University of the Witwatersrand/National Health Laboratory Service, Johannesburg, South Africa., Michelow P; Department of Anatomical Pathology, Faculty of Health Sciences, University of the Witwatersrand/National Health Laboratory Service, Johannesburg, South Africa., Chen WC; National Cancer Registry, National Health Laboratory Service, Johannesburg, South Africa.; Strengthening Oncology Services Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Joffe M; Strengthening Oncology Services Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Fjeldbo CS; Department of Radiation Biology, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Lyng H; Department of Radiation Biology, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.; Department of Physics, University of Oslo, Oslo, Norway., Sukumar S; Women's Malignancies Program, Department of Oncology, Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, 1650 Orleans Street, Rm 144, CRB1, Baltimore, MD, 21231, USA. saras@jhmi.edu.

Publikováno v: Clinical epigenetics [Clin Epigenetics] 2024 Apr 20; Vol. 16 (1), pp. 56. Date of Electronic Publication: 2024 Apr 20.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

2-Hydroxypropyl-β-cyclodextrin (HPβCD) as a Potential Therapeutic Agent for Breast Cancer.

Autor: Saha ST; School of Molecular and Cell Biology, University of the Witwatersrand, Private Bag 3, WITS-2050, Johannesburg 2050, South Africa., Abdulla N; School of Molecular and Cell Biology, University of the Witwatersrand, Private Bag 3, WITS-2050, Johannesburg 2050, South Africa., Zininga T; Department of Biochemistry and Microbiology, University of Venda, Private Bag X5050, Thohoyandou 0950, South Africa.; Department of Biochemistry, Stellenbosch University, Stellenbosch 7600, South Africa., Shonhai A; Department of Biochemistry and Microbiology, University of Venda, Private Bag X5050, Thohoyandou 0950, South Africa., Wadee R; Department of Anatomical Pathology, School of Pathology, University of the Witwatersrand/National Health Laboratory Service, Johannesburg 2000, South Africa., Kaur M; School of Molecular and Cell Biology, University of the Witwatersrand, Private Bag 3, WITS-2050, Johannesburg 2050, South Africa.

Publikováno v: Cancers [Cancers (Basel)] 2023 May 18; Vol. 15 (10). Date of Electronic Publication: 2023 May 18.